These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20620514)

  • 21. Hepatitis C infection in hemodialysis patients: Protective against oxidative stress?
    Sezer S; Tutal E; Aldemir D; Türkoglu S; Demirel OU; Afsar B; Ozdemir FN; Haberal M
    Transplant Proc; 2006 Mar; 38(2):406-10. PubMed ID: 16549132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma lipid peroxidation and antioxidiant nutrients in type 2 diabetic patients.
    Peerapatdit T; Patchanans N; Likidlilid A; Poldee S; Sriratanasathavorn C
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S147-55. PubMed ID: 17718256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intragraft localization of activated nuclear factor kappaB in recurrent hepatitis C virus disease following liver transplantation.
    Gaweco AS; Wiesner RH; Porayko M; Rustgi VK; Yong S; Hamdani R; Harig J; Chejfec G; McClatchey KD; Van Thiel DH
    Hepatology; 2000 May; 31(5):1183-91. PubMed ID: 10796896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent hepatitis C virus disease after liver transplantation and concurrent biliary tract complications: poor outcome.
    Katz LH; Mor E; Brown M; Bar-Nathan N; Shaharabani E; Sulkes J; Pappo O; Tur-Kaspa R; Ben-Ari Z
    Clin Transplant; 2006; 20(4):465-70. PubMed ID: 16842523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival outcome after hepatic retransplantation for hepatitis C virus-positive and -negative recipients.
    Jain A; Orloff M; Abt P; Kashyap R; Mohanka R; Lansing K; Romano J; Bozorgzadeh A
    Transplant Proc; 2005 Sep; 37(7):3159-61. PubMed ID: 16213336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation.
    Sreekumar R; Gonzalez-Koch A; Maor-Kendler Y; Batts K; Moreno-Luna L; Poterucha J; Burgart L; Wiesner R; Kremers W; Rosen C; Charlton MR
    Hepatology; 2000 Nov; 32(5):1125-30. PubMed ID: 11050065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver transplantation and hepatitis C virus. Results in a Spanish center since 1989.
    Loinaz C; Lumbreras C; Moreno E; Colina F; Fuertes A; Gómez R; Jiménez C; González-Pinto I; García I; Rojas J; Bellorín C
    Hepatogastroenterology; 2001; 48(41):1435-42. PubMed ID: 11677981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantation.
    Gawrieh S; Papouchado BG; Burgart LJ; Kobayashi S; Charlton MR; Gores GJ
    Liver Transpl; 2005 Oct; 11(10):1207-13. PubMed ID: 16184568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrent hepatitis C virus infection after liver transplantation--long-term follow-up with respect to the HCV genotypes/subtypes.
    Arnold JC; Töx U; Goeser T; Otto G; Müller HM; Hofmann WJ; Stremmel W; Theilmann L
    Z Gastroenterol; 1997 Apr; 35(4):255-61. PubMed ID: 9163889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of lipid peroxidation product, nitrite and antioxidant levels in newly diagnosed and two months follow-up patients with pulmonary tuberculosis.
    Lamsal M; Gautam N; Bhatta N; Toora BD; Bhattacharya SK; Baral N
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):695-703. PubMed ID: 17883009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does interferon use prior to liver transplant influence hepatitis C outcomes following transplantation?
    Smallwood GA; Devine R; Fasola C; Stieber AC; Heffron TG
    Transplantation; 2008 Dec; 86(12):1795-8. PubMed ID: 19104424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors that identify survival after liver retransplantation for allograft failure caused by recurrent hepatitis C infection.
    Neff GW; O'Brien CB; Nery J; Shire NJ; Nishida S; delaGarza J; Montalbano M; Safdar K; Ruiz P; Rideman E; Gascon JA; Tzakis AG; Madariaga J; Rudich SM
    Liver Transpl; 2004 Dec; 10(12):1497-503. PubMed ID: 15558835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study.
    Tam LS; Li EK; Leung VY; Griffith JF; Benzie IF; Lim PL; Whitney B; Lee VW; Lee KK; Thomas GN; Tomlinson B
    J Rheumatol; 2005 Feb; 32(2):275-82. PubMed ID: 15693087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does hepatitis C increase the accumulation of advanced glycation end products in haemodialysis patients?
    Arsov S; Graaff R; Morariu AM; van Oeveren W; Smit AJ; Busletic I; Trajcevska L; Selim G; Dzekova P; Stegmayr B; Sikole A; Rakhorst G
    Nephrol Dial Transplant; 2010 Mar; 25(3):885-91. PubMed ID: 19934094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C.
    Yagci G; Fernandez LA; Knechtle SJ; D'Alessandro AM; Chin LT; Musat AI; Lucey MR; Said A; Pirsch JD; Leverson G; Kalayoglu M
    Transplant Proc; 2008; 40(1):219-23. PubMed ID: 18261591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study.
    Biselli M; Gramenzi A; Del Gaudio M; Ravaioli M; Vitale G; Gitto S; Grazi GL; Pinna AD; Andreone P; Bernardi M;
    J Clin Gastroenterol; 2010 Jan; 44(1):52-7. PubMed ID: 19581813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of immunosuppression and effect of hepatitis C virus on new onset of diabetes mellitus in liver transplant recipients.
    Sánchez-Pérez B; Aranda Narváez JM; Santoyo Santoyo J; Fernández-Aguilar JL; Suárez Muñoz MA; González-Sánchez AJ; Pérez Daga JA; Ramírez Plaza CP; Carrasco Campos J; Jiménez Mazure C; Becerra Ortíz R
    Transplant Proc; 2008 Nov; 40(9):2994-6. PubMed ID: 19010171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcome of hepatitis C virus infection after liver transplantation.
    Böker KH; Dalley G; Bahr MJ; Maschek H; Tillmann HL; Trautwein C; Oldhaver K; Bode U; Pichlmayr R; Manns MP
    Hepatology; 1997 Jan; 25(1):203-10. PubMed ID: 8985291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between hepatitis C, diabetes mellitus, and race. a case-control study.
    Thuluvath PJ; John PR
    Am J Gastroenterol; 2003 Feb; 98(2):438-41. PubMed ID: 12591065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of patient and graft survival following liver transplantation for hepatitis C.
    Charlton M; Seaberg E; Wiesner R; Everhart J; Zetterman R; Lake J; Detre K; Hoofnagle J
    Hepatology; 1998 Sep; 28(3):823-30. PubMed ID: 9731579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.